• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON GRIESHABER AG GRIESHABER REVOLUTION DSP FORCEPS; FORCEPS, OPHTHALMIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON GRIESHABER AG GRIESHABER REVOLUTION DSP FORCEPS; FORCEPS, OPHTHALMIC Back to Search Results
Catalog Number 705.44
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Hemorrhage/Blood Loss/Bleeding (1888)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.Babu naresh, kohli piyush, ramachandran obuli, ramasamy kim.Comparison of surgical performance of internal limiting membrane peeling using a 3-d visualization system with conventional microscope.2018;49:941-945.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A literature article stated that a patient experienced peeling related hemorrhages using opathalmic operating surgical forceps.It also stated that the peeling related hemorrhages significantly higher in analog microscope group than digitally assisted vitreoretinal system group.Current patient condition is unknown.
 
Additional Manufacturer Narrative
No lot number was identified within the individual articles and therefore within this complaint, which is why the associated manufacturing documentation could not be reviewed.All product and batch history records are quality reviewed prior to product release, ensuring that all products on the market fulfill the relevant requirements.Since the questionnaire retrospectively review articles, no sample is available to be provided to the responsible site for an in-depth investigation.Not enough information was provided to properly complete an investigation.The root cause of this complaint could not be identified.The exact root cause for the reported event is unknown.Therefore, no specific action can be taken.Within the framework of the mentioned nci, an overall risk assessment was performed and concluded that no further actions are required.Additionally, complaints are reviewed and monitored at regular intervals for adverse trends.No additional actions are needed.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GRIESHABER REVOLUTION DSP FORCEPS
Common Device Name
FORCEPS, OPHTHALMIC
Manufacturer (Section D)
ALCON GRIESHABER AG
winkelriedstrasse 52
schaffhausen 8203
SZ  8203
Manufacturer (Section G)
ALCON GRIESHABER AG
winkelriedstrasse 52
schaffhausen 8203
SZ   8203
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key17732483
Report Number3003398873-2023-00192
Device Sequence Number20435879
Product Code HNR
UDI-Device Identifier07612717064263
UDI-Public07612717064263
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Literature
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue Number705.44
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/15/2023
Supplement Date Received by Manufacturer11/15/2023
Initial Report FDA Received Date09/12/2023
Supplement Report FDA Received Date12/11/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-